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Conjugatable Water-Soluble Pt (II) and Pd(II) 
Porphyrin Complexes: Novel Nano- and Molecular 
Probes for Optical Oxygen Tension Measurement in 
Tissue Engineering 
F. Giuntini,a† V. M. Chauhan,b J. W. Aylott,b G. A. Rosser,c A. Athanasiadis, d A. 
Beeby,c A. J. MacRobert, d R. A. Brownd and R. W. Boyle*a
Measurement of oxygen tension in compressed collagen sheets was performed using matrix-
embedded optical oxygen sensors based on platinum(II) and palladium(II) porphyrins 
supported on polyacrylamide nanoparticles. Bespoke, fully water-soluble, monofunctionalised 
Pt(II) and Pd(II) porphyrin complexes designed for conjugation under mild conditions were 
obtained using microwave-assisted metallation. The new sensors display a linear response (1/τ 
vs. O2) to varying oxygen tension over a biologically relevant range (7.0 x 10-4 to 2.7 x 10-1 
mM) in aqueous solutions; a behaviour that is maintained following conjugation to 
polyacrylamide nanoparticles, and following embedding of the nanosensors in compressed 
collagen sheets, paving the way to innovative approaches for real-time resolution of oxygen 
gradients throughout 3D matrices useful for tissue regeneration. 
Introduction 
In the recent years, interest in the development of novel 
porphyrins for biomedical applications grew beyond the 
boundaries of the therapeutic field. An increasing number of 
publications in the area illustrates the potential of these species 
as probes for a variety of diagnostic techniques (fluorescence,1, 
2 ultrasound and photo-acoustic tomography,3, 4 MRI,5 PET6, 7), 
and as sensors.8 Pt(II) and Pd(II) porphyrins, in particular, 
received great attention due to their oxygen sensing  behaviour; 
thanks to their high phosphorescence quantum yields, long-
lived triplet states, large Stokes shifts, and favourable 
photostability, such species emerged as suitable leads for the 
development of oxygen probes tailored for a variety of specific 
applications.9-12 Optical oxygen sensing relies on the oxygen-
dependent decrease of triplet lifetime and phosphorescence 
intensity, which is caused by the collisional quenching of the 
phosphor’s triplet state. The efficiency of porphyrins as oxygen 
probes in biological environments is widely documented in the 
literature. Species such as coproporphyrin and 
octaethylporphyrin have been successfully employed as stand-
alone probes or in conjunction with cell-penetration enhancers 
to measure intracellular oxygen tension in respiring cells.13-22 
Recently, the association of Pd(II) and Pt(II) porphyrins and 
benzoporphyrins with dendrimeric structures was reported as a 
strategy to obtain probes that remain confined to the 
extracellular compartment, and their efficiency for the 
measurement of oxygen tension in the intercellular space has 
been demonstrated.23-28 The ligation of oxygen-sensing 
porphyrins with nanoparticles29-35 and polymers36-49 has also 
been explored, as an efficient way to circumvent their low 
water solubility, and to prevent any undesired interaction of the 
dye with subcellular structures. 
The pivotal importance of measuring oxygen levels and 
detecting hypoxia gradients has long been recognised in the 
medical field,50 but the recent advances in regenerative 
medicine sparked a renewed interest in the pursuit of innovative 
strategies for oxygen detection. The need to circumvent some 
intrinsic disadvantages of electrode-based oxygen sensing 
methods, which proved detrimental especially for tissue 
engineering applications, has led to an intense research activity 
in the field of optical oxygen sensing. Unlike electrode-based 
methods, optical oxygen sensors cause very limited oxygen 
depletion in the sample, are minimally invasive and less 
affected by environmental/experimental conditions,11, 51 and are 
amenable to conventional imaging techniques and incorporation 
into miniaturised devices,2 and allow simultaneous analysis of 
multiple samples: thanks to these evidences, the popularity of 
optical oxygen sensing increased, and progressively more 
studies featuring optical oxygen sensing for intra- and 
extracellular oxygen measurements, both in 2D52-54 and 3D55-58 
cell cultures, appear in the literature.  
The regeneration of functional tissue from cell-seeded supports 
depends on the supply of oxygen and nutrients: an inadequate 
supply of oxygen to the core cells of an engineered 3D tissue 
construct leads to the formation of oxygen gradients and 
hypoxic zones, which can cause the construct to fail. The onset 
of oxygen gradients in pre-vascularised engineered tissues is 
governed by the depth of the cell core (gradient length) and the 
cell density/metabolic activity of cells along that path.59, 60 The 
complexity of predicting these factors together with the lack of 
straightforward methods to measure oxygen gradients, 
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encouraged the general assumption that all cells sitting deeper 
than 0.5 mm from the surface will be compromised.60 Studies 
conducted in connective tissue, however, indicated that this 
assumption might be over-pessimistic,61, 62 and as such, 
negatively bias or discourage the assessment of the suitability 
of new materials to sustain cell growth. Straightforward 
approaches to monitor oxygen gradients are therefore highly 
desirable to support the design and development of improved 
materials for 3D engineered tissue constructs.63 
Unlike amperometric measurements, which probe oxygen 
tension in the immediate vicinity of the electrode tip, optical 
oxygen sensing proved able to resolve oxygen gradients in a 
cell-seeded construct in situ and in a non-invasive fashion.52, 58, 
64, 65 Harrington et al. showed how an optical probe uniformly 
distributed in a 3D cell-seeded construct can provide real-time 
information on the global behaviour of the device during cell 
growth and migration, using standard luminescence detections 
and imaging techniques.57 Following our interest in the sensing 
applications of porphyrins,66, 67 we undertook a project aimed at 
the development of porphyrin-based oxygen nanosensors for 
incorporation in compressed collagen matrices designed for 
tissue engineering applications.60 The use of nanoparticle-
supported probes embedded in the matrix prevents the diffusion 
of the probe molecules, which could lead to cell toxicity. In 
order to allow the biocompatible ligation of the oxygen sensor 
to the support of interest (e.g.: collagen fibres, polymers, etc.) 
the desired sensors would need to be: (1) water-soluble and (2) 
provided with a functional group to allow covalent conjugation 
to the desired support. Unfortunately, most known oxygen-
sensing porphyrins are hydrophobic, and unless suitably 
derivatised, they can only be dissolved in organic solvents often 
incompatible with the integrity/functionality of the support 
(especially biomolecules). Furthermore, the few oxygen-
sensing porphyrins which lend themselves to bioconjugation in 
aqueous media display several copies of the same reactive 
group, and require further derivatisation to prevent the 
formation of multiple conjugation products.68 
In order to circumvent the issues mentioned above, we designed 
a set of porphyrins bearing (1) charged groups, either positive 
or negative, to promote water solubility to allow for 
conjugation in aqueous environment, and (2) a single 
carboxylic group for selective conjugation in mild, 
biocompatible conditions (Figure 1). The availability of both 
positively and negatively charged species allows the choice of 
the most appropriate sensor for the nature of the matrix in use, 
to ensure that covalent ligation occurs and avoid the formation 
of ion pairs with the support (e.g.: a negatively charged probe 
and substrates bearing an overall positive charge). 
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Figure 1: General formula of the water-soluble (W.S.), conjugatable (c.g.) oxygen-
sensing porphyrins. 
This article describes the synthesis of the new water-soluble 
mono-functionalised Pt(II) and Pd(II) porphyrin complexes, 
their conjugation to polyacrylamide nanoparticles, and the 
assessment of the responsiveness of the species obtained to 
varying oxygen concentration over a biologically relevant 
range. We also report the preliminary evidences of the potential 
of these species as oxygen probes in biomimetic matrices, as 
shown by the results of oxygen tension measurements 
performed with nanoconjugates embedded in compressed 
collagen gels. 
Results and discussion 
Synthesis 
The synthesis of the cationic derivatives 3 and 4 started from 
the methyl ester of tris-pyridyl-carboxyphenyl porphyrin 1. 
(Scheme 1).69 Metal insertion in meso-pyridyl porphyrins is 
hampered by the tendency of the pyridyl nitrogens to act as 
ligands for the metal ion in the macrocycle, leading to the 
formation of stable tridimensional polymeric complexes.70-73 
Following an approach we previously adopted,66 we overcame 
this problem by converting 1 into the corresponding cationic 
species 2 by treatment with iodomethane in NMP74 Treatment 
of 2 with PdCl2 in methanol afforded the desired derivative in 
good yields. The platinum complexes was prepared following 
the procedure described by Pasternack et al.,75 which involves 
refluxing an aqueous solution of the cationic porphyrin in the 
presence of the labile cationic complex [Pt(DMSO)2(H2O)2]2+, 
prepared in situ by ligand exchange from Pt(PhCN)2Cl2 upon 
treatment with DMSO and AgNO3: this method afforded the 
desired species in 84% yield. Both 3 and 4 were converted into 
the corresponding free acid by saponification with lithium 
hydroxide in water. 
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Scheme 1 
All attempts to generate the platinum and palladium complexes 
of sulfonated porphyrin 5 under the conditions described above 
failed; the use of the classic conditions for platinum insertion 
into porphyrin macrocycles, involving treatment with 
Pt(PhCN)2Cl2 in refluxing benzonitrile in an inert 
atmosphere,38, 76, 77 was ruled out by the poor solubility of 5 in 
non-polar solvents. Similarly, palladium insertion by treatment 
with PdCl2 in refluxing DMF78 was ineffective because of the 
lack of solubility of the starting material. Attempts to carry out 
sulfonation on the platinum or the palladium complexes of 5-
(4-carboxyphenyl)-10,15,20-tris-phenyporphyrin (e.g.: conc. 
H2SO4, 70 °C,79 or ClSO3H, 40 °C80) led to metal loss and/or 
2 | J. Name., 2012, 00, 1-3 
Journal Name ARTICLE 
degradation of the starting material. Effective conditions to 
promote metallation of our porphyrins were met when we 
turned our attention to microwave irradiation (MWI). The use 
of MWI in organic synthesis has increased considerably over 
the last decades because it has proved to be a general tool to 
shorten reaction times and significantly enhance yields and 
regioselectivity of a wide variety of transformations.81 
Microwave-promoted insertion of group 10 metals in meso-
tetraarylporphyrins and meso-tetraaryl-2,3-
dihydroxyporphyrins has been reported previously,82 but, to the 
best of our knowledge,  it has never been applied to the 
synthesis of water-soluble derivatives. The water-soluble 
Pt(DMSO)2(H2O)2, prepared following Pasternak’s procedure, 
was transferred in a microwave reactor and irradiated in the 
presence of 5 at 200 °C over 20 minutes, to yield complex 6. In 
similar conditions, MWI of 5 in the presence of water-soluble 
PdCl2 let to the conversion to 7 within 5 minutes (Scheme 1).  
The striking efficiency of this approach compelled us to revisit 
the synthesis of complex 3, which was obtained from 2 in 10 
minutes and in 90% yield under MWI (vs. overnight reflux in 
conventional heating conditions). The insertion of Pd(II) and 
Pt(II) in water-soluble porphyrins is sparingly reported in the 
literature, and the few procedures described are lengthy and low 
yielding. Furthermore, it is worthy to point out that none of the 
procedures reported to date was ever adopted for the 
preparation of conjugatable derivatives. To the best of our 
knowledge, the MWI-assisted strategy developed in our lab 
represent the first expeditious and high yielding approach for 
the synthesis of water-soluble mono-functionalised Pt(II) and 
Pd(II) porphyrins: the general applicability of this method to 
otherwise sluggish metal insertion reactions holds the potential 
to pave the way to novel biomedical applications of porphyrins 
complexes. 
Conjugation of porphyrins 3, 4, 6, and 7 to amino-
functionalised polyacrylamide nanoparticles was carried out in 
water by carbodiimide-mediated coupling in the presence of N-
hydroxysuccinimide (Scheme 2).66, 83 The porphyrin-coated 
nanospecies 8-11 were obtained in good yields and the dye 
loading was evaluated spectrophotometrically, on the basis of 
the molar absorption coefficient of the porphyrins at their 
absorption maxima. (Table 1). The ligation conditions were 
optimised using poly(L-lysine) and amino-dextran as models 
for macromolecular supports (see Supporting Information). 
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Table 1: Nanoconjugates recovery yields and loading. 
compound yield 
(%) 
loading 
(nmol/mg) No. M 
8 Pt 84 13 
9 Pd 70 12 
10 Pt 63 16 
11 Pd 86 11 
Photophysical Characterisation 
All the species synthesised are fully water-soluble; their 
absorption spectra in water show an intense Soret band in the 
395–405 nm spectral window, and Q-bands in the 525–545 nm 
region. The average half-width of the Soret band (>30 nm) for 
the non-conjugated porphyrins suggests the occurrence of 
extensive aggregation, a frequently reported behaviour of meso 
alkylpyridiniumyl and sulfonatophenyl porphyrins in water.84 
Porphyrins 3 and 6 and the corresponding nanoconjugates 
display the typical blue-shifted Soret bands of Pt porphyrins 
(Figure 2).77 As expected, the conjugation to nanoparticles 
affects the absorptive and emissive behaviour of the 
chromophores: examples of the absorption and emission spectra 
are shown in Figure 2 (the complete series of spectra is reported 
in the Supporting Information). As a general trend, the 
association to the polyacrylamide support causes a red-shift in 
the λmax and a broadening of the Soret band, behaviour that can 
be attributed to dye-support interaction or to self-aggregation of 
the dye within the polymer.12, 85 
Figure 2: (A): Absorption (solid line) and emission (dashed line) spectra of 
porphyrin 3 and nanoconjugates 8; (B): absorption (solid line) and emission 
(dashed line) spectra of porphyrin 6 and nanoconjugates 10. Spectra were 
recorded in deionised water. 
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Conjugation of the porphyrins to nanoparticles also causes a 
marked decrease in the triplet state yields, as reflected by the 
decrease in the singlet oxygen quantum yield, (Table 2), which 
can be ascribed to enhanced non-radiative decay of the excited 
states of polymer-supported porphyrins due to dye-matrix 
interactions. Measurement of triplet lifetime in de-oxygenated 
aqueous solution shows that the presence of the polyacrylamide 
matrix does not affect the lifetime of the phosphors, suggesting 
that triplet decay in the absence of oxygen is not enhanced by 
the interaction of the porphyrin with the matrix. Longer triplet 
lifetimes are consistently observed throughout the series for the 
palladium-containing species 4, 7 and 9, 11. 
Prolonged irradiation with continuous red light (645 nm, band 
width ca. 17 nm, > 20 min.) caused a limited reduction of the 
intensity of the Soret band, both for the porphyrins and the 
nanoconjugates: (Table 2) this marginal photobleaching is 
unlikely to hamper the oxygen-sensing performance of these 
species, as the measurements are normally carried out by 
exciting the phosphors with significantly lower light doses 
compared to those used in the present experiments.86 
Table 2: Photophysical properties of porphyrins and conjugates. 
species λmax (nm)a 
logελmax 
(±σ)a λem (nm)
b stability (±σ)c lifetimed (µs) ΦΔ (±σ)e 
3 402 5.01 (±0.01) 667 84.5 (± 2.1) 10.0 (± 0.2) 0.72 (±0.07) 
4 415 4.97 (±0.01) 700 94.7 (± 1.9) 120.0 (± 3.0) 0.75 (±0.07) 
6 398 5.18 (±0.02) 663 94.4 (± 0.9) 30.0 (± 0.1) 0.74 (±0.07) 
7 410 5.30 (±0.01) 700 89.7 (± 2.3) 294.0 (± 4.0) 0.76 (±0.07) 
8 407 - 664 93.6 (± 0.7) 13.0 (± 0.1) 0.30 (±0.03) 
9 410 - 700 94.9 (± 0.4) 95.0 (± 2.0) 0.36 (±0.03) 
10 403 - 673 96.8 (± 1.2) 29.0 (± 0.1) 0.32 (±0.03) 
11 415 - 700 85.9 (± 1.2) 260.0 (± 4.0) 0.35 (±0.03) 
a: Soret band, measured in deionised water (±0.1 nm); b: (±0.2 nm), λexc.  = λmax. , measured in deionised water; c: residual absorbance (%) following 20 min 
irradiation of an aqueous solution showing an A(λmax) = 1.0; d: λexc. = 351 nm, measured in deoxygenated aqueous solutions showing an A351 = 0.1; e: singlet 
oxygen quantum yield measured in D2O. 
Oxygen sensing: Time-Resolved Domain 
The oxygen-induced collisional quenching of phosphorescence 
is a dynamic process described by the Stern-Volmer 
relationship (1), stating that the ratio be-tween the triplet 
lifetime in the absence and the presence of the quencher is 
linear to the concentration of the quencher.87  
τ0/τ = K sv[O2] + 1    (1) 
where τ and τ0 are the triplet lifetime of the chromophore in the 
presence and in the absence of the quencher, respectively, [O2] 
is the molar concentration of oxygen, and Ksv is the Stern-
Volmer constant, defined as the product of the triplet lifetime in 
the absence of the quencher and the bimolecular quenching rate 
constant (i.e.: KSV = τ0kq). 
The phosphorescence lifetimes of porphyrins 3, 4, 6, and 7, and 
of the porphyrin-decorated nanoparticles 8-11 were determined 
in aqueous solution at oxygen concentrations ranging from 7.0 
x 10-4 to 2.7 x 10-1 mM (see Supporting Information for 
experimental details), and the data were processed using a 
Stern-Volmer type analysis (1/τ = kq[O2] + 1/τ0) to obtain the 
bimolecular quenching rate constants, kq (Table 3). All the 
species display oxygen-dependent phosphorescence and a good 
linearity of 1/τ over a biologically relevant oxygen 
concentration range. The 1/τ vs. O2 plot for porphyrin 3 is 
shown in Figure 3 (remaining plots are shown in the Supporting 
Information). The four porphyrins displayed comparable values 
of kq (≈109 M-1s-1), indicating that for these particular probes, 
neither the nature of the inner metal nor the charges associated 
to the macrocycle seem to have a major impact on the 
efficiency of the collisional quenching of phosphorescence by 
oxygen. The kq of the nanoconjugates are one order of 
magnitude smaller than the ones observed for the corresponding 
porphyrins (i.e.: ≈108 M-1s-1), suggesting that the conjugation to 
polyacrylamide nanoparticles causes a reduction in the oxygen 
sensitivity of the porphyrin probes: it can be hypothesized that 
the association with a polymeric support partially shields the 
phosphor from colliding with molecular oxygen, thereby 
reducing the efficiency of the quenching.88, 89 
Figure 3: 1/τ vs. O 2 concentration (mM) scatter plot and regression line for 
porphyrin 3. 
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Table 3 
species 
time resolved steady state 
kq (±σ)  
(M-1 s-1) R
2 kq (±σ) (mmHg-1 s-1) 
kq (±σ) 
(M-1 s-1) R
2 
porphyrins 
3 2.81 x 109 (±0.15 x 109) 0.989 4.76 x 103 (±0.25 x 103) 3.06 x 109 (±0.18 x 104) 0.986 
4 2.46 x 109 (±0.06 x 109) 0.997 4.16 x 103 (±0.11 x 103) 2.31 x 109 (±0.07 x 109) 0.987 
6 3.12 x 109 (±0.07 x 109) 0.998 5.28 x 103 (±0.11 x 103) 2.66 x 109 (±0.34 x 109) 0.935 
7 2.74 x 109 (±0.10 x 109) 0.995 4.64 x 103 (±0.17 x 103) 1.79 x 109 (±0.08 x 109) 0.992 
nanoconjugates 
8 6.27 x 108 (±0.29 x 108) 0.985 1.06 x 103 (±0.05 x 103) 6.39 x 108 (±0.25 x 108) 0.991 
9 4.46 x 108 (±0.11 x 108) 0.996 7.54 x 102 (±0.19 x 102) 5.52 x 108 (±0.22 x 108) 0.989 
10 1.95 x 108 (±0.01 x 108) 0.985 3.29 x 102 (±0.15 x 102) 2.64 x 108 (±0.27 x 108) 0.995 
11 1.85 x 108 (±0.05 x 108) 0.994 3.14 x 102 (±0.09 x 102) 2.05 x 108 (±0.05 x 108) 0.995 
Bimolecular quenching constants and correlation coefficients for porphyrins 3, 4, 6, and 7, and nanoconjugates 8-11 over the oxygen concentration range 7 x 10-4 to 2.7 x 10-1 mM. 
(a: value extrapolated from the calibration line) 
Oxygen sensing: steady state measurements 
According to the Stern-Volmer equation, in the presence of 
purely dynamic quenching: 
I0/I = τ0/τ = K sv[O2] + 1 (where: KSV = τ0kq) (2) 
where I0/I is the ratio of the phosphorescence intensity in the 
absence (I0) and in the presence (I) of the quencher. According 
to Eq. 2, calibration of the sensor and oxygen tension 
measurements can be based on the quenching of the 
phosphorescence emission rather than the triplet lifetime. 
Although steady-state measurements of quencher concentration 
are less sensitive and more easily affected by the experimental 
conditions and by environmental factors (e.g.: phosphor 
concentration, background fluorescence, etc.), whenever 
applicable, they allow the use of simpler and cheaper 
instrumentation. Steady-state oxygen measurement have been 
successfully applied to cultured cells,12, 34 in vivo,90, 91 and also 
found applications in microfluidic devices.92, 93 With the 
exception of porphyrin 6, for which the correlation coefficient 
for the linear regression is lower, all porphyrins and 
nanoconjugates display linear relationships between I0/I and 
oxygen concentration, throughout the range 7.0 x 10-4 - 2.7 x 
10-1 mM (Table 3). Figure 3 shows the emission spectra of 
porphyrin 3 at different concentration of oxygen (A), and the 
corresponding scatter plot and regression line (B).  
Figure 5 shows the intensity and lifetime Stern-Volmer plots 
for porphyrin 3, and Table 4 reports the data obtained for all the 
species (remaining Stern-Volmer plots are provided in the 
Supporting Information). In most of the cases there is good 
agreement between the values of the KSV values  of the lifetime 
and intensity plots, indicating that the predominant pathway of 
triplet deactivation for these species under the experimental 
conditions de-scribed is due to dynamic quenching by oxygen, 
and that no static quenching is involved. 
Figure 4: Fluorescence emission profiles (A) and I0 /I Stern-Volmer plot (B) for 
porphyrin 7 (arrow indicates decreasing O 2 concentration). 
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Figure 5: Lifetime () and intensity () Stern-Volmer plots for porphyrin 3. 
All probes exhibit a marked enhancement of phosphorescence 
intensity and triplet lifetime in deoxygenated- compared to air-
saturated solutions; the free porphyrins display larger I0/I and 
τ0/τ ratios than the corresponding nanoconjugate, and similarly, 
the I0/I and τ0/τ values observed for Pd(II) complexes are 
higher than the ones found for the corresponding Pt(II) species, 
confirming that larger values of τ0 confer higher oxygen 
sensitivity on the probes. The linearity of time-resolved and 
steady-state responses over a biologically relevant oxygen con-
centration range shows the suitability of these porphyrin-based 
probes for oxygen measurements in the biomedical field. 
Table 4 
species 
time resolved steady state 
KSV (±σ) R2 τ0/τmin KSV (±σ) R2 I0/Imin 
porphyrins 
3 3.06 x 104 (±0.18 x 104) 0.989 8.96 2.90 x 104 (±0.18 x 104) 0.986 9.65 
4 2.95 x 105  (±0.08 x 105) 0.997 82.2 2.78 x 105 (±0.08 x 105) 0.987 72.73 
6 9.33 x 104  (±0.19 x 104) 0.998 25.8 8.15 x 104 (±1.07 x 104) 0.935 23.18 
7 8.07 x 105 (±0.29 x 105) 0.995 213.04 5.26 x 105 (±0.24 x 105) 0.992 140.87 
nanoconjugates 
8 8.28 x 103 (±0.39 x 103) 0.985 3.30 7.89 x 103 (±0.33 x 103) 0.991 3.17 
9 6.06 x 104 (±0.15 x 104) 0.996 17.74 5.54 x 104 (±0.21 x 104) 0.989 14.90 
10 5.60 x 103  (±0.26 x 103) 0.985 2.46 7.66 x 103 (±0.77 x 103) 0.995 2.99 
11 4.82 x 104 (±0.38 x 104) 0.994 13.68 5.43 x 104 (±0.14 x 104) 0.995 15.87 
Data for the lifetime and intensity Stern-Volmer plots for the oxygen-sensing porphyrins and nanoconjugates. 
Oxygen sensing in compressed collagen scaffolds 
The promising oxygen-sensing behaviour shown by the sensors 
encouraged us to undertake a study to investigate the possibility of 
employing the nanoconjugates to monitor oxygen diffusivity in 3D 
collagen matrices. To this aim, we embedded nanoconjugate 9 in 
compressed rat tail Type I collagen matrices. The compressed 
collagen matrix has a much lower water content and therefore higher 
collagen density than uncompressed collagen hydrogel. The collagen 
density of ca. 11% w/w is comparable with that found in tissues, 
which makes these compressed gels excellent biomimetic matrices. 
The compressed matrices were shaped into rods and suspended in 
0.01 M PBS solution in a sealed quartz cuvette, and the oxygen con-
centration in the medium was varied by streaming nitrogen through 
the solution.1, 94 A calibrated fibre-optic oxygen sensing probe was 
placed halfway along the length of the rod’s longitudinal axis, with 
the purpose of verifying the equilibration of oxygen levels during 
nitrogen degassing and to provide a comparison measurement. Time-
resolved phosphorescence signals from the embedded nanosensors 
were detected using a fibre-optic probe placed adjacent to the surface 
of the collagen matrix (Figure 6 and Supporting Information).  
Figure 6: Experimental setting for oxygen sensing in com-pressed collagen rods. 
Figure 7 shows the phosphorescence decay of the nanoconjugate in 
the compressed collagen gel (A) and the linear Stern-Volmer plot of 
lifetime decay (B) at different levels of oxygen, illustrating the 
efficiency of this nanoconjugate for oxygen sensing in a biomimetic 
collagen matrix and its potential for applications in 3D constructs. 
The lower value of KSV observed in the collagen matrix (see Figure 
7, A and B) is ascribable to two main factors, namely (1) the faster 
oxygen diffusion in solution compared to the collagen gel,62 and (2) 
the dye-matrix interaction which partially shields the phosphors from 
interactions with the surrounding environment. The triplet lifetime 
shows a three-fold increase (τ0/τ min) from the highest oxygen 
concentration examined to the deoxygenated sample, providing the 
I0/I = 30592[O2] + 0.9174
τ0/τ = 28962[O2] + 0.7366
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necessary sensitivity over the dynamic range of interest. We also 
observed that the conjugates were well retained in the collagen 
matrix and no significant leaching into the PBS solution occurred: 
no detectable phosphorescence was observed in the PBS solution 
using the same optical configuration following removal of the 
collagen sample.  
From these data it emerges that nanoconjugate 9 maintain their 
oxygen responsiveness in a relatively complex and heterogeneous 
environment such as compressed collagen. These preliminary 
evidences point out the potential of these species as oxygen 
concentration reporters in cell-seeded tissue models, where, unlike 
fibre-optic probes and electrodes, they could provide a real-time 3D 
map of oxygen distribution throughout the support and assist in 
evaluating the rate of oxygen diffusion and oxygen consumption by 
the cells. 
Figure 7: Triplet lifetime decay (A) and corresponding Stern-Volmer plot (B) of 
nanoconjugate 9 embedded in collagen matrix over the 0-52 mmHg oxygen
tension range (corresponding to 0 – 8.84 x 10-2 mM). Stern-Volmer constant is 
KSV=0.0958 mmHg-1 (19.494 mM-1) and the bimolecular quenching rate constant 
is k q=355 mmHg-1s-1 (R2=0.9955). 
Conclusions 
Novel water-soluble oxygen-sensing phosphors based on Pt(II) 
and Pd(II) complexes of porphyrins were synthesised. The 
molecules were designed to bear charged moieties and a single 
carboxylic group to ensure water solubility and to prevent the 
formation of cross-linked conjugates, respectively, making 
these species extremely versatile towards ligation with amino-
functionalised substrates of different chemical nature; in 
particular, the ligation of the probes to bio-macromolecules is 
feasible owing to the possibility of performing the conjugation 
in aqueous solutions and in mild conditions. To achieve the 
metal insertion of Pt(II) and Pd(II) in the free water-soluble 
macrocycles, we developed a microwave-assisted method that 
rapidly affords the desired species in high yields. Ligation to 
amino-functionalised polyacrylamide nanoparticles gave 
nanoconjugates with loading ratios varying between 11 and 13 
nmol/mg. All species display oxygen-dependent 
phosphorescence in time-resolved domain and steady state, 
with triplet lifetimes and emission intensities varying linearly 
with the oxygen concentration, over a physiologically relevant 
range. Importantly, we showed that the nanoprobes can be 
easily incorporated and retained in a compressed collagen gel, 
where their oxygen-sensing behaviour is maintained. These 
data encourage the use of the sensors as investigative tools to 
monitor the oxygen flow in matrices for tissue regeneration 
construct. The incorporation of the oxygen sensing porphyrins 
within ratiometric and/or dual nanosensors (e.g.: oxygen and 
pH sensors), and the covalent ligation of the molecular probes 
to the scaffold matrix are currently under investigation in our 
laboratories. 
Experimental Section 
General Remarks: 1H and 13C NMR spectra were recorded on 
JEOL Eclipse 400 and JEOL Lambda 400 spectrometers 
(operating at 400 MHz for 1H and 100 MHz for 13C). CDCl3, 
DMSO-d6, and MeOH-d3 were used as solvents. Chemical 
shifts (δ) are reported in parts per million (ppm), referenced to 
either CHCl3 (1H, 7.26 ppm; 13C, 77.16 ppm) or DMSO (1H, 
2.50 ppm; 13C, 39.52 ppm) or MeOH (1H, 3.31 ppm; 13C, 49.00 
ppm). Coupling constants (J) are recorded in Hz and significant 
multiplicities described by singlet (s), doublet (d), triplet (t), 
quadruplet (q), broad (br), multiplet (m), or doublet of doublets 
(dd). A Malvern Photon Correlation Spectrometer equipped 
with a 70 mW blue laser operating at 470 nm at an angle of 90° 
was used for the PCS measurements. The measurements were 
performed at room temperature, at a concentration of 5 mg/mL 
of nanospecies in 7 mM aqueous NaCl, unless otherwise stated, 
and the solutions were filtered through a 0.22 µm filter (Millex 
GP) previous to the measurements. ESI mass spectra were 
performed on a Thermofisher LTQ orbitrap XL (EPSRC Mass 
Spectrometry Service, Swansea), or on a Varian 500-MS ion 
trap spectrometer, equipped with a Varian Prostar 212LC 
binary gradient pumping system and a Varian ProStar 410 
autosampler. A standard Varian ESI source was used operating 
in +ve ion mode. Data was acquired and processed using 
Varian Workstation software. MALDI mass spectra were 
performed on a Bruker Reflex IV MALDI-TOF, operated in 
reflectron mode and monitoring positive ions. Data was 
acquired and processed using Bruker Compass software. 1,8-
Dihydroxy-9,10-dihydroanthracen-9-one (dithranol) was used 
as the matrix. UV−visible spectra were recorded on a Varian 
Cary 50 UV/vis spectrophotometer (wavelength accuracy: ± 
0.24 nm). Fluorescence spectra (uncorrected) were recorded on 
a Cary Eclipse Fluorimeter. The singlet Δoxygen quantum yield, 
ΦΔ , was determined using by time-resolved phosphorescence 
measurements.95, 96  Samples dissolved in D2O and allowed to 
equilibrate with air and were excited using the third harmonic 
of a Q-switched Nd:YAG laser (355 nm). A CuSO4 filter was 
used upstream of the solution to remove residual 1064 nm 
radiation in the pump beam. Typical pulse energies used were 
in the range 0.1–1 mJ per pulse. A North Coast E0-817P Ge 
photodiode/amplifier combination detected the singlet oxygen 
phosphorescence at right angles to the incident laser beam. The 
sample was placed in a fluorescence cuvette with a 10 mm path 
length close to the detector. The singlet oxygen luminescence 
was selected with a 1270 nm silicon interference filter 
(bandpass, 30 nm) placed close to the detector.  Singlet oxygen 
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quantum yields were determined relative to rose Bengal (ΦΔ  = 
0.76). Photostability experiments were carried out with a LED 
source, with 126 diodes arranged equally in a panel of 10 X 16 
cm. The power is 50W/m2 at the working distance, and the peak 
maximum is 642 nm (spectrum reported in the Supplementary 
Information). Flash chromatography was carried out on silica 
gel 60 (MP Biomedicals, 32−63 μm). Analytical TLC was 
carried out on aluminium sheets pre-coated with silica gel 60 
(Fluka, 0.2 mm thick). Reactions under microwave irradiation 
were performed in a CEM Discovery SP-D at a power of 100 
W. Chemical reagents were purchased from Sigma-Aldrich, 
Fluka, Acros, Lancaster, and Alfa Aesar at the highest grade of 
purity available, and were used as received unless otherwise 
stated. Dichloromethane and THF were dried by filtration 
through alumina and stored over activated molecular sieves.97 
All other solvents were purchased from Fisher Scientific and 
used as received. Argon and oxygen gas gases were purchased 
from BOC Gases (Manchester, United Kingdom). Deionized 
water (18.2 MΩ) was generated by Elga Purelab Ultra 
(ULXXXGEM2) or from a Millipore Milli-Q system. Gel 
filtrations were performed on Sephadex® G-25 medium, using 
pre-packed PD-10 columns (GE Healthcare, UK), using 
deionised water as the eluent. Filtrations through membranes 
were performed on Sartolon® polyamide filters, 25 mm, 0.20 
μm pores. Solid phase extractions were performed on Supelco 
Discovery DSC-18 cartridges (1 g). RP-HPLC analyses were 
performed on a system consisting of a Perkin Elmer series 200 
LC pump, and a Perkin Elmer 785A UV/vis detector. The 
separations were performed on a Gemini C18, 5 µ, 150 x 4.6 
mm, 110 Å (Phenomenex, UK), equipped with a SecurityGuard 
C18 (ODS) 4 x 3.0 mm ID guard column (Phenomenex, UK) at 
a flow rate of 1 mL/min. Method A: the mobile phase consisted 
of 0.1% TFA in water (solvent A) and 0.1% TFA in acetonitrile 
(solvent B). Gradient: 0.0–10.0 min, 0-95% B; 10.0–15.0 min, 
95% B; 15.0–15.1 min, 95-5% B; 15.1–18.0 min, 5% B. 
Method B: the mobile phase consisted of 0.1 M NH4AcO in 
water (solvent A) and 0.1 M NH4AcO in 50% aqueous AcCN 
(solvent B). Gradient: 0–15.0 min, 2-100%, B; 15.0–18.0 min 
100%, B; 18.0–18.1 min, 100-2% B; 18.1–20.0, min 2% B. 
Amino-functionalised polyacrylamide nanoparticles were 
obtained according to methods reported in the literature.67, 98 5-
(4-carboxymethylphenyl)-10,15,20-tris(4-
methylpyridinium)porphyrin trichloride,71 and 5-(4-
carboxymethylphenyl)-10,15,20-tris(4-
sulfonatophenyl)porphyrin trisodium99 were synthesised 
according to methods reported in the literature. 
Oxygen concentration measurements in time-resolved 
domain. Phosphorescence lifetimes were recorded using a 
time-correlated photon counting spectrometer. The samples 
were held in a four-sided quartz cuvette equipped with a 
degassing bulb. The samples were excited using the output of a 
pulsed nitrogen laser (VSL-337i OEM), which provided a 10Hz 
pulse train of pulse duration < 5 ns at 337 nm, with a pulse 
energy of ca. 5 μJ.  Emission was collected at 90° to the 
excitation source and the emission wavelength was selected 
using a monochromator (Bentham TM300) and the selected 
light detected using a red-sensitive photon counting 
photomultiplier module (Hamamatsu H10682-1).  The arrival 
times of multiple photons were recorded from each laser shot 
using a multi-channel scaler, and the data from a minimum of 
10,000 laser shots was acquired to furnish the emission decay. 
Prior to measurements the sample was completely degassed by 
a series of freeze-pump-thaw cycles.  Once degassed the 
concentration of oxygen in the sample cell was adjusted by 
back-filling the cell with a known pressure of air and according 
to Henry’s Law, [O2] ∝ pair.  In this way the concentration of 
oxygen could be varied from 0 – 0.27 M. 
Oxygen concentration measurements under steady-state 
conditions. Dissolved oxygen concentrations were measured 
using an OceanOptics NeoFox (NFB0181) fluorescence-based 
optical sensor probe which was immersed in solutions of 
oxygen-sensitive fluorophores (0.01 mg/mL, 10 mL) and 
suspensions of oxygen-sensitive nanoparticles (0.50 mg/mL, 10 
mL) in deionised water. The dissolved oxygen concentration of 
these solutions/suspensions was varied by bubbling in argon 
and oxygen gas, representing 0% and 100% oxygen 
concentration, respectively. Oxygen-dependent fluorescence 
intensities of samples were recorded using a Varian Cary 
Eclipse fluorescence spectrophotometer. Table 5 shows 
excitation and emission wavelengths used to determine oxygen-
dependent fluorescence response. For dissolved oxygen 
concentrations below atmospheric oxygen concentrations 
stirring samples were deoxygenated by bubbling in argon gas. 
Once the samples were deoxygenated the argon source was 
removed and the samples were allowed to re- equilibrate to 
atmospheric oxygen concentrations. For oxygen concentration 
above atmospheric oxygen concentrations, stirring samples 
were oxygenated by bubbling in oxygen gas. Once the samples 
were fully oxygenated the oxygen source was removed and the 
samples were allowed to equilibrate to atmospheric oxygen 
concentrations. Fluorescence spectra of re-equilibrating 
samples were taken at regular intervals, from which an oxygen-
dependent fluorescence response was determined. 
Table 5 
species λexc (nm) λem (nm) λmaxem-λmaxexc (nm) 
3 400 670 270 
4 415 700 285 
6 400 665 265 
7 410 700 290 
8 405 665 260 
9 410 715 305 
10 405 670 265 
11 415 705 290 
Oxygen concentration measurements in collagen 
sheets. Compressed collagen matrix construction: The gels 
were prepared with 80% (by volume) of rat tail collagen type I 
(First Link Ltd, UK) with a protein concentration of 2.05 mg/ml 
in 0.6% acetic acid, 10% 10x Eagles MEM solution (Gibco 
Chemicals, UK) and 10% 20 μM of nanoparticle sample 9 in 
0.01M Dulbecco’s Phosphate Buffered Saline (PBS). Gels 
without nanoparticles were also prepared as controls with 80% 
rat tail collagen, 10% 10x MEM and 10% PBS. The mixture 
was neutralised with 5 M NaOH based on the indicator colour 
changes and placed in an aluminium mould of 2.2x3.3x1 cm 
dimensions. The mixture was then incubated for 30 minutes to 
allow the gel to set. The collagen gel was then compressed 
between two nylon meshes to reduce the water content for 5 
minutes giving a flattened sheet approximately 50 μm thick. 
The sheet was rolled tightly to produce a cylindrically shaped 
rod of approximately 2 mm diameter and 20 mm length.60  
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Setup for oxygen and luminescence measurements.60 A thin 
fibre-optic oxygen sensing probe (Oxylab pO2 E Series sensor, 
Oxford Optronix Ltd.) was inserted halfway along the 
longitudinal axis of the folded collagen gel. The gel containing 
the probe was transferred into a PBS solution within a 1 cm 
square quartz cuvette with the collagen surface placed adjacent 
to one of the cuvette walls. The cuvette was sealed with a 
plastic film to prevent re-oxygenation of the sample during the 
deoxygenation procedure. During the measurements a magnetic 
stirrer was used to keep the oxygen concentration homogenous 
in the solution. The removal of oxygen was performed by 
bubbling the solution with oxygen-free nitrogen gas (BOC Ltd) 
introduced via a hypodermic needle inserted through the film 
sealing the cuvette, placed adjacent to the gel. The oxygen 
concentration within the gel was then adjusted to the desired 
partial pressure and allowed to stabilise. 
Time Resolved Luminescence Decay Measurements: The 
phosphorescence decays were measured using time resolved 
photon counting. The samples were excited using a 532 nm 
passively Q-switched diode-pumped solid state Nd:YAG laser 
(Lumanova GmbH, Germany) with the beam focused into a 
bifurcated fibre-optic coupler with an SMA termination 
(Avantes BV). The laser was pulsed at a repetition rate of 2.8 
kHz and a pulse length of 3 ns, with a mean power of c. 0.5 
mW at the fibre probe tip giving a spot size of c. 1 mm 
diameter on the gel. A fast photodiode (1 ns rise time, PDM-
400, Becker-Hickl, Berlin, Germany) was used to synchronise 
the laser pulse with the photon counting detection system. 
Excitation light from the laser was delivered through one arm 
(400 micron core) of the bifurcated fibre-optic bundle. 
5-(4-Methoxycarbonylphenyl)-10,15,20-tris(4-
methylpyridinium)porphyrinato platinum (II) tri-chloride: 
The water-soluble Pt(DMSO)2(H2O)2 was synthesised 
according to a modification of the procedure reported by 
Pasternack et al..75 A suspension of platinum dibenzonitrile 
dichloride100 (524 mg, 1.11 mmol) in DMSO (5 mL) was stirred 
at room temperature for 3 hours. De-ionised water (10 mL) was 
added to the solution, and the resulting suspension was treated 
with 2 (300 mg, 0.37 mmol) and silver nitrate (189 mg, 1.11 
mmol). The mixture was protected from light and stirred at 
room temperature for 3 h. Silver chloride was then removed by 
filtration through celite, the mixture was transferred to a 
microwave reaction vessel equipped with a stirring bar, flushed 
with argon for 10 minutes and exposed to microwave heating 
(200 °C, 100 mW, 10 min). The reaction mixture was diluted 
with deionised water and filtered through celite. The filtrate 
was treated with a 10% aqueous solution of NH4PF6, leading to 
the precipitation of the porphyrin. The precipitate was collected 
by centrifugation and dissolved in acetone. The resulting 
solution was treated with 10% TBAC in acetone to induce the 
precipitation of the title compound, which was collected by 
centrifugation, washed with acetone, and further purified by 
crystallisation from methanol/diethyl ether. (Brick red. 340 mg, 
90%). M.p.(°C): > 300. HPLC (Method A): tR: 7.20; 1H NMR: 
(d6-DMSO) δ: 9.44-9.41 (6H, 10+15+20-m-Ar), 8.95 (br, 6H, 
β-H), 8.90-8.81 (m, 8H, β-H and 10+15+20-o-Ar), 8.35 (2H, d, 
J 8.2, 5-o-Ar), 8.25 (2H, d, J 8.2, 5-m-Ar), 4.64-4.57 (m, 9H, 
NCH3), 3.97 (s, 3H, COOCH3); 13C NMR: (d6-DMSO) δ: 
166.3, 155.5, 144.4, 140.6, 139.3, 139.2, 138.9, 134.0, 131.7, 
129.8, 128.1, 123.2, 117.8, 117.5, 52.6, 47.9; MALDI-MS (+ve, 
dithranol) (m/z): calcd. for C46H36N7O2Pt: 913.267, found: 
913.361 [M- 3Cl]+; UV/vis: (H2O) λ (%): 404 (100), 513 
(11.9), 543 (4.5); log ε421: 5.10 
5-(4-Methoxycarbonylphenyl)-10,15,20-tris(4-
methylpyridinium)porphyrinato palladium (II) tri-chloride 
3: To a solution of 2 (220 mg, 0.27 mmol) in 1-
methylpyrrolidin-5-one (10 mL) Pd(II) diacetate (360 mg, 0.53 
mmol) was added as a solution in methanol (3 mL). The 
mixture was purged with Ar for 5 minutes, then it was heated at 
50 °C for 1 hour, cooled at room temperature and filtered 
through celite. Diethyl ether (100 mL) was added to the filtrate 
and the resulting suspension was filtered through paper. The 
precipitate was dissolved in water and the resulting solution 
was treated with 10% aqueous NH4PF6. The precipitate was 
collected by centrifugation and dissolved in acetone. The 
resulting solution was treated with 10% TBAC in acetone to 
induce the precipitation of the title compound, which was 
collected by centrifugation, washed with acetone, and further 
purified by crystallisation from methanol/diethyl ether. (201 
mg, 80%). M.p.(°C): > 300. HPLC: tR: 7.16; 1H NMR: (d6-
DMSO) δ: 9.55-9.51 (6H, 10+15+20-m-Ar), 9.10 (br, 4H, β-
H), 9.02-8.95 (m, 10H, β-H and 10+15+20-o-Ar), 8.38 (2H, d, 
J 7.8, 5-o-Ar), 8.33 (2H, d, J 7.8, 5-m-Ar), 4.73-4.71 (m, 9H, 
NCH3), 4.05 (s, 3H, COOCH3); 13C NMR: (d6-DMSO) δ: 
166.3, 155.9, 144.7, 144.3, 141.2, 139.9, 139.8, 139.6, 134.2, 
132.7, 132.3, 132.1, 131.8, 129.8, 128.0, 122.7, 117.2, 116.8, 
52.6, 47.8; MALDI-MS(+ve, dithranol) (m/z): calcd. for 
C45H34N7O2Pd: 824.19, found: 824.19 [M- 3Cl]+; UV/vis: 
(H2O) λ (%): 419 (100), 529 (10.2), 565 (3.4); log ε421: 5.29 
General procedure for the hydrolysis of methyl ester (A). 5-
(4-Carboxyphenyl)-10,15,20-tris(4-
methylpyridinium)porphyrinato platinum (II) trichloride 3: 
A solution of porphyrin 5-(4-methoxycarbonylphenyl)-
10,15,20-tris(4-methylpyridinium)porphyrinato platinum (II) 
tri-chloride (100 mg, 0.10 mmol) in deionised water (5 mL) 
was treated with LiOH (44 mg, 0.98 mmol). The mixture was 
stirred at room temperature for 30 minutes, and then it was 
diluted with water (20 mL). The resulting solution was treated 
with a 10% aqueous solution of NH4PF6, leading to the 
precipitation of the porphyrin. The precipitate was collected by 
centrifugation and dissolved in acetone. The resulting solution 
was treated with 10% TBAC in acetone to induce the 
precipitation of the title compound, which was collected by 
centrifugation, washed with acetone, and further purified by 
crystallisation from methanol/diethyl ether. M.p.(°C): > 300. 
HPLC (Method A): tR: 6.49 min; 1H NMR: (d6-DMSO) δ: 
9.36-9.33 (6H, m, 10+15+20-m-Ar), 8.91 (s, 6H, β-H), 8.87-
8.80 (m, 8H, β-H and 10+15+20-o-Ar), 8.19 (2H, d, J 8.2, 5-o-
Ar), 7.95 (2H, d, J 8.2, 5-m-Ar), 4.61 (s, 9H, NCH3); 13C NMR: 
(d6-DMSO) δ: 180.6, 155.7, 144.4, 141.1, 140.8, 139.6, 139.1, 
138.6, 137.5, 133.9, 132.9, 131.8, 131.5, 131.0, 129.4, 126.1, 
125.9, 117.6, 117.0, 57.4, 48.0; MALDI-MS(+ve, dithranol) 
(m/z): calcd. for C45H34N7O2Pt: 899.24, found: 899.29 [M- 
3Cl]+; UV/vis: (H2O) λ (%): 402 (100), 514 (10.0), 543 (4.5); 
log ε402: 5.01 
5-(4-Carboxyphenyl)-10,15,20-tris(4-
methylpyridinium)porphyrinato palladium (II) tri-chloride 
4: The species was synthesised according to the general 
procedure A. Scale: 0.10 mmol. Yield: 81%, 80 mg, brick-red 
solid. M.p.(°C): > 300 . HPLC (Method A): tR: 6.53 min; 1H 
NMR: (d6-DMSO) δ: 6.48-6.47 (6H, m, 10+15+20-m-Ar), 9.07 
(4H, s, β-H), 8.97 (10H, s, β-H and 10+15+20-o-Ar), 8.26 (2H, 
d, J 6.9, 5-o-Ar), 8.03 (2H, d, J 6.9, 5-m-Ar), 4.67 (s, 9H, 
NCH3); 13C NMR: (d6-DMSO) δ: 167.7, 156.1, 144.3, 141.7, 
139.9, 139.5, 133.2, 133.0, 132.1, 131.8, 131.5, 127.7, 117.1, 
116.3, 47.8; MALDI-MS (+ve, dithranol) (m/z): calcd. for 
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C46H36N7O2Pt: 913.267, found: 913.361 [M- 3Cl]+; UV/vis: 
(H2O) λ (%): 417 (100), 525 (11.5), 560 (5.1); log ε417: 4.97 
5-(4-Carboxyphenyl)-10,15,20-tris(4-
sulfonatophenyl)porphyrinato platinum(II) trisodium 6: A 
suspension of platinum dibenzonitrile dichloride (140 mg, 0.30 
mmol) in DMSO (1.2 mL) was stirred at room temperature for 
3 hours. Deionised water (10 mL) was added to the solution, 
and the resulting suspension was treated with silver nitrate (101 
mg, 0.60 mmol), protected from light and stirred at room 
temperature for 3 h.  Silver chloride was then removed by 
filtration through celite, and the mixture was transferred to a 
microwave reactor equipped with a stirring bar. 5 (160 mg, 0.16 
mmol) was added to the solution; the mixture was flushed with 
argon for 10 minutes and exposed to microwave heating (200 
°C, 100 mW, 20 min). Upon cooling, the solution was filtered 
through celite, and the porphyrin was recovered by filtration 
following precipitation with acetone. The precipitate was 
dissolved in a 1 mM aqueous sodium hydroxide, and 
precipitated with acetone. The solid was taken in water, 
purified by solid phase extraction, the eluate was evaporated to 
dryness and the desired compound was crystallised from 
methanol/diethyl ether. (Brown/red solid, 181 mg, 97%). 
M.p.(°C): > 300. HPLC (Method B): tR: 8.98; 1H NMR: (d6-
DMSO) δ: 8.72-8.67 (8 H, m, β-H), 8.31 (2H, d, J 8.2, 5-o-Ar), 
8.24 (2H, d, J 8.2, 5-o-Ar), 8.08 (6H, d, J 8.0, 10+15+20-m-
Ar), 7.98 (6H, d, J 8.0, 10+15+20-o-Ar); 13C NMR: (d6-
DMSO) δ: 170.3, 167.4, 147.9, 144.7, 140.4, 140.1, 140.0, 
133.8, 133.1, 131.1, 130.9, 130.7, 128.1, 124.3, 122.2, 122.1, 
121.3; ESI-MS (-ve) (m/z): calcd. for [C45H25N4O11PtS3]3-/3: 
363.0120, found: 363.0106 [M- 3Na]3-/3; UV/vis: (H2O) λ (%): 
398 (100), 509 (9.5), 541 (1.9); log ε398: 5.18 
5-(4-Carboxyphenyl)-10,15,20-tris(4-
sulfonatophenyl)porphyrinato palladium(II) trisodium 7: 
80 A solution of 5 (200 mg, 0.21 mmol) and palladium 
dichloride (73 mg, 0.41 mmol) in methanol (10 mL) in a 
microwave reactor vessel was purged with Ar for 10 minutes 
and exposed to microwave heating (90 °C, 100 mW, 10 min). 
Upon cooling, the mixture was filtered through celite and 
evaporated to dryness. The solid was taken up in 1 mM aqueous 
NaOH and the porphyrin was precipitated with acetone, and 
collected by filtration. The solid was taken in water, purified by 
solid phase extraction, and the eluate was evaporated to 
dryness. The desired compound was crystallised from 
methanol/diethyl ether. (Brick red solid, 220 mg, 98%). 
M.p.(°C): > 300. HPLC (Method B): tR: 9.09; 1H NMR: (d6-
DMSO) δ: 8.82-8.78 (8 H, m, β-H), 8.36 (2H, d, J 8.0, 5-o-Ar), 
8.29 (2H, d, J 8.0, 5-o-Ar), 8.14 (6H, d, J 8.0, 10+15+20-m-
Ar), 8.04 (6H, d, J 8.0, 10+15+20-o-Ar); 13C NMR: (d6-
DMSO) δ: 167.5, 147.8, 144.9, 140.9, 140.8, 140.4, 134.0, 
133.2, 131.4, 131.2, 127.9, 124.3, 121.6, 121.5, 120.8; ESI-MS 
(-ve) (m/z): calcd. for [C45H25N4O11PdS3]3-/3: 332.9914, 
found: 332.9907 [M- 3Na]3-/3; UV/vis: (H2O) λ (%): 411 
(100), 521 (9.1), 556 (1.7); log ε411: 5.30 
General procedure for the conjugation of amino-reactive 
porphyrins to amino-functionalised sub-strates: 
Nanoconjugates 8. A solution of porphyrin 3 (2 mg, 2.0 x 10-3  
mmol) in deionised water was treated with EDC (2 mg, 1.0 x 
10-2 mmol) and NHS (2 mg, 1.7 x 10-2 mmol) and allowed to 
stand at room temperature for 30 minutes. The solution was 
then added to a dispersion of amino-functionalised nanospecies 
(100 mg) in deionised water (20 mL). The resulting mixture 
was shielded from light and shaken for 8 hours on a rotating 
shaker. The desired conjugated species were purified by gel 
filtration. Ethanol was added to the eluate, and the particles 
were isolated by filtration through membrane and dried in 
vacuo (light orange-red solid, 62 mg, 62% recovery). PCS: Zave  
(nm) 75.9±5.5; UV/vis: (H2O) λ (%): 407 (100), 515 (22.9), 
541 (16.9) 
Nanoconjugates 9. The conjugated nanospecies were obtained 
following the general procedure, using amino-functionalised 
nanospecies (100 mg) and porphyrin 4 (3 mg, 3.0 x 10-3 
mmol). The desired nanoparticles were obtained as a light 
orange solid. (63 mg, 63% recovery). PCS: Zave (nm) 54.8±2.9; 
UV/vis: (H2O) λ (%): 412 (100), 526 (12.4), 563 (5.0) 
Nanoconjugates 10. The conjugated nanospecies were 
obtained following the general procedure, using amino-
functionalised nanospecies (70 mg) and porphyrin 6 (4 mg, 3.4 
x 10-3 mmol). The desired nanoparticles were obtained as a 
light orange solid. (60 mg, 70% recovery). PCS: Zave (nm) 
174.3±50.4; UV/vis: (H2O) λ (%): 403 (100), 527 (10.7), 561 
(3.6) 
Nanoconjugates 11. The conjugated nanospecies were 
obtained following the general procedure, using amino-
functionalised nanospecies (70 mg) and porphyrin 7 (4 mg, 3.7 
x 10-3 mmol). The desired nanoparticles were obtained as a 
light orange solid. (58 mg, 86% recovery). PCS: Zave (nm) 
59.8±15.5; UV/vis: (H2O) λ (%): 412 (100), 515 (12.9), 541 
(6.9) 
Abbreviations 
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